about
Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial componentsInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadTherapeutic suppression of premature termination codons: mechanisms and clinical considerations (review)Novel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons.Environmental exposure to organochlorine pesticides and deficits in cochlear status in childrenIn vitro interaction of Pseudomonas aeruginosa with human middle ear epithelial cellsCrystal structures of a bioactive 6'-hydroxy variant of sisomicin bound to the bacterial and protozoal ribosomal decoding sitesLong term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.Autophagy is essential for mouse sense of balanceChronic exposure to low frequency noise at moderate levels causes impaired balance in mice.An otoprotective role for the apoptosis inhibitor protein survivin.Autophagy in the Vertebrate Inner Ear.siRNA-mediated knock-down of NOX3: therapy for hearing loss?Constraint-induced sound therapy for sudden sensorineural hearing loss--behavioral and neurophysiological outcomes.Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss.Ambient noise levels in the chemotherapy clinic.Minocycline protection of neomycin induced hearing loss in gerbils.Notch signaling limits supporting cell plasticity in the hair cell-damaged early postnatal murine cochleaAntioxidant treatment with coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model.Real-time quantification of Xeroderma pigmentosum mRNA from the mammalian cochlea.A protective mechanism against antibiotic-induced ototoxicity: role of prestinFeathers and fins: non-mammalian models for hair cell regeneration.Caprin-1 is a target of the deafness gene Pou4f3 and is recruited to stress granules in cochlear hair cells in response to ototoxic damage.c-Myb knockdown increases the neomycin-induced damage to hair-cell-like HEI-OC1 cells in vitroAminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes.New trends in aminoglycosides use.Aminoglycoside modifying enzymes.Adverse Drug Reactions of Long-term Intravenous Antibiotics in Patients with Pyogenic Spondylitis.5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion.Pharmacogenomics of antimicrobial agents.Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutationsSuppression of nonsense mutations as a therapeutic approach to treat genetic diseases.Exploring adverse drug events at the class level.Suppression of premature termination codons as a therapeutic approach.An Evaluation of the Protective Effects of Thymoquinone on Amikacin-Induced Ototoxicity in Rats.A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosidesAutophagic flux, a possible mechanism for delayed gentamicin-induced ototoxicity.Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases.Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs.
P2860
Q24616291-C249114C-42F8-4AEF-BB3F-7F074FB75519Q26822988-628A1D49-88AE-4485-BBB5-0E9640205689Q26853614-C73A2BCF-6D41-4E92-8813-0BDD1D2793F7Q27307798-69D88FD7-514D-4B02-B182-B5E47F3DC758Q27313926-8E2874B3-0AB0-4425-B16C-4391EF868F04Q27315407-A60B90AC-BA47-4DC8-A6CF-CD1E156BA1BBQ27684075-810E6161-1056-4716-94A0-35E751B6875DQ28540814-8D7CC2A8-524C-4A17-A3D3-53C7F0BC9F57Q28591463-89E69B09-3E0C-428C-B8C3-4E1E98651DC5Q28727693-0326AFB6-C4DB-4EB3-B219-8C5ED5749C04Q29871534-BC4A0741-29E5-4D93-851E-3BE634841269Q30354605-5CAC5D34-352D-455E-8216-3EE3ADFF8A1EQ30355898-121508C9-75CE-4A58-B683-ECBBFC0DEE72Q30358431-02E253F3-5EDF-43A3-99BC-F17393C3F6E6Q30384292-105A3D49-A78A-4C2D-AE86-B574EFBE957BQ30394142-6649BC12-D813-4CDF-8F38-5A385D925871Q30412597-902A2613-0B80-4CD2-86E9-47A7CE863511Q30449542-481B8349-26C2-4955-9808-B20CC121F3F5Q30465930-1EF78321-E5AE-4E80-99C9-D874C281E642Q30473910-3295CDFC-F8CF-4388-BFF2-993C87F9C639Q30476793-0D16EBC3-2BEB-4FAF-8E1D-A8A9B83170BAQ30480942-8E9CDA84-FB25-4790-BCCD-8E8F52950570Q30498633-2FE6CF94-C9F8-4AC1-A5AC-DBC6D5515AB5Q30835814-B12EC203-2F48-4170-AB69-33EC932D2CADQ33681878-A66840A1-5126-460E-A204-E0D26BF6BC56Q33951177-0B99286A-6E1E-411D-9C4A-E32A98720BDCQ34354185-0BB73F99-4B4C-43FA-B5BC-C26880106F1DQ34390948-25687425-6136-4008-BE00-59FBBDA029D9Q34443734-A440AEFF-CE54-4FDF-B2BA-BD359DEFB3E8Q34977413-D3F499D1-6173-460E-997C-8ACFF30DD022Q35105699-7E15ECB1-45DB-45C1-A06C-33E0E6352B06Q35287888-016D03C1-E4B2-426E-9225-3198E3B24D7CQ35559500-D36CEA4C-0CDA-46B3-A218-D7AD589E7E7DQ36203719-4F12E58B-F759-4A62-BF46-5E99691B294BQ36323000-D85FE90E-E3F1-40FD-AE75-5206978BC0B9Q36726249-D6E247EB-ED44-4830-9BA8-7B4CCD4655FFQ37618066-451BCFFA-7D8A-4800-B5D9-E42D0DBF855CQ37715425-25778B73-FA64-47A0-828D-CFA026B26229Q37726532-AA70ED41-F658-4DD5-9773-2CA9669577C8Q37810481-FAF28AA3-1314-4730-BB98-AD735680CAF7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aminoglycoside induced ototoxicity.
@en
Aminoglycoside induced ototoxicity.
@nl
type
label
Aminoglycoside induced ototoxicity.
@en
Aminoglycoside induced ototoxicity.
@nl
prefLabel
Aminoglycoside induced ototoxicity.
@en
Aminoglycoside induced ototoxicity.
@nl
P1433
P1476
Aminoglycoside induced ototoxicity.
@en
P2093
O'Neil W Guthrie
P356
10.1016/J.TOX.2008.04.015
P407
P577
2008-04-29T00:00:00Z